Rare diseases have tenfold higher impact on healthcare costs; study
A new study has suggested that the economic burden posed by rare diseases is around 10 times higher than for common “mass market” conditions. The […]
A new study has suggested that the economic burden posed by rare diseases is around 10 times higher than for common “mass market” conditions. The […]
With over 40% of all medicines in the pipeline aimed at rare diseases, the future looks positive for increasing the number of treatments available. However, […]
While Covid has made many aspects of living with a rare disease more difficult, it has inspired policies and techniques that could help rare disease […]
Rare diseases affect a fraction of the population – 450 million+ people globally. However, its effects can be equally severe and life-threatening as other prevalent […]
Rare diseases impact between 3.5%-5.9% of the world’s population. This Rare Disease Day, RBW Consulting’s Emma Thorp discusses why the consultancy is taking revenue earned […]
How has rare disease care changed over the last few years? And what might we expect from the next five? We attended the Rare Disease […]
To help pharma companies understand what life is really like for patients with a rare disease, a new resource has been released to coincide with […]
Copyright © 2024 | WordPress Theme by MH Themes